Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Elexacaftor/Tezacaftor/Ivacaftor and Neuropsychiatric Symptoms: Nonclinical and Clinical Studies

Submitted by Anna Hakala on Wed, 10/22/2025 - 14:55
  • Read more about Elexacaftor/Tezacaftor/Ivacaftor and Neuropsychiatric Symptoms: Nonclinical and Clinical Studies

The Causal Relationship Between Palmitoylation Genes and Parkinson's Disease: A Mendelian Randomization Study

Submitted by Anna Hakala on Wed, 10/22/2025 - 10:46
  • Read more about The Causal Relationship Between Palmitoylation Genes and Parkinson's Disease: A Mendelian Randomization Study

Association between serum copper and COPD: Insights from NHANES 2011-2016 and Mendelian randomization study

Submitted by Anna Hakala on Tue, 10/21/2025 - 14:15
  • Read more about Association between serum copper and COPD: Insights from NHANES 2011-2016 and Mendelian randomization study

Assessing Causality between Obstructive Sleep Apnea and Erectile Dysfunction: A Bidirectional Mendelian Randomization Study

Submitted by Anna Hakala on Tue, 10/21/2025 - 14:14
  • Read more about Assessing Causality between Obstructive Sleep Apnea and Erectile Dysfunction: A Bidirectional Mendelian Randomization Study

Genomic data-driven framework for drug target discovery in atrial fibrillation

Submitted by Anna Hakala on Mon, 10/20/2025 - 12:19
  • Read more about Genomic data-driven framework for drug target discovery in atrial fibrillation

Sex hormones and meningiomas risk: a Mendelian randomization and immunohistochemical analysis

Submitted by Anna Hakala on Mon, 10/20/2025 - 11:29
  • Read more about Sex hormones and meningiomas risk: a Mendelian randomization and immunohistochemical analysis

Genetic Validation of ABI3 p.S209F Variant and Its effects On Early Brain Pathology in Asymptomatic Elderly Individuals

Submitted by Anna Hakala on Mon, 10/20/2025 - 11:27
  • Read more about Genetic Validation of ABI3 p.S209F Variant and Its effects On Early Brain Pathology in Asymptomatic Elderly Individuals

Removing genetic effects on plasma proteins enhances their utility as disease biomarkers

Submitted by Anna Hakala on Mon, 10/20/2025 - 11:14
  • Read more about Removing genetic effects on plasma proteins enhances their utility as disease biomarkers

Multivariate GWAS reveals shared genetic etiology and pleiotropic loci across carcinomas

Submitted by Anna Hakala on Mon, 10/20/2025 - 11:12
  • Read more about Multivariate GWAS reveals shared genetic etiology and pleiotropic loci across carcinomas

Integrative Proteome- and Phenome-Wide Assessment Uncovers Causal Protein Drivers and Drug Targets for Heterogeneous Kidney Diseases

Submitted by Anna Hakala on Mon, 10/20/2025 - 11:06
  • Read more about Integrative Proteome- and Phenome-Wide Assessment Uncovers Causal Protein Drivers and Drug Targets for Heterogeneous Kidney Diseases

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • Current page 47
  • Page 48
  • Page 49
  • Page 50
  • Page 51
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement